110 results
TAVI and FFR-guided PCI vs. SAVR and CABG in AS with complex or multivessel CAD: the TCW Trial
16 Dec 2024
The TCW trial found that FFR-guided PCI with TAVI offers favorable one-year outcomes, including lower rates of all-cause mortality, MI, disabling stroke, revascularisation, valve reintervention, and severe bleeding, compared to CABG with SAVR.
Reviewer
SAVR or TAVR: what is best for female patients?
25 Nov 2024 – From PCR London Valves 2024
Wondering which is the better option for female patients—SAVR or TAVR? Don’t miss this exchange between Hendrik Treede and Hélène Eltchaninoff. They explore the unique challenges and nuances of valve interventions for women, highlighting evolving strategies to optimize treatment and improve outcomes.
You may also be interested...
Efficacy and safety of Edoxaban in anticoagulant therapy early after surgical bioprosthetic valve replacement: ENBALV trial
16 Nov 2024
Edoardo Zancanaro provides his take on the ENBALV trial presented by Chisato Izumi at AHA 2024 in Chicago.
Author
GLORIOUS - Efficacy of restrictive versus liberal oxygenation or Exenatide in patients undergoing coronary artery bypass grafting or aortic valve replacement – a randomised clinical trial
21 Nov 2024
Edoardo Zancanaro provides his take on the GLORIOUS trial presented by Sebastian Wiberg at AHA 2024 in Chicago.
Author
AHA 2024: get the interventional cardiology perspective!
13 Nov 2024
Stay up to date with what is new and hot in interventional cardiology at #AHA24 in Chicago.
Challenging aortas: how to perform TAVI after coarctation surgery?
26 Sep 2024
How do you navigate the complexities of performing TAVI on aortas previously treated for coarctation surgery, while ensuring patient safety through meticulous planning and expert precision? Analyse this image to find out more!
TRIGISTRY: Benefit of isolated surgical valve repair or replacement for functional tricuspid regurgitation and long-term outcomes stratified by the TRI-SCORE
31 Aug 2024
Alex Sticchi provides his take on the TRIGISTRY study presented by Julien Dreyfus at the ESC Congress 2024 in London.
Simultaneous publication in European Heart Journal, ehae578
Author
MATTERHORN - Transcatheter versus surgical mitral valve repair in patients with heart failure and secondary mitral regurgitation
01 Sep 2024
Yohei Ohno provides his takeaways from the results of the MATTERHORN trial presented by Volker Rudolph at the ESC Congress 2024 in London.
Author
TAVI in patients with low surgical risk: an expanding indication?
28 Jun 2024
Discover the risks and benefits of TAVI in patients with low surgical risk, building on the data of the latest randomised trial in this field, the DEDICATE trial, of which Moritz Seiffert was one of the leading investigators.
Controlled ring expansion during aortic valve-in-valve: a proof-of-concept CT-scan analysis
24 Jun 2024
Analyze this EIJ image to see how surgical aortic bioprostheses with expandable ring technology can significantly enhance future ViV procedures.
